NCMAG123 Bevacizumab advice document: July 2025
Posted on:
Document Type
NCMAG advice
Process guidance
Uncategorised
Summary
Bevacizumab in combination with fluoropyrimidine-based chemotherapy for the first line treatment of adult patients with metastatic carcinoma of the colon or rectum. On-label use and off-patent medicine.
Decision: Supported